Thailand

Thailand has built medical tourism into a national industry unlike any other. With 2.6 million international patients in 2024, it consistently outranks every competitor on raw volume, and the infrastructure justifies that dominance: 62–63 Joint Commission International-accredited facilities place Thailand fourth globally and first in Southeast Asia, up from just 13 accredited sites in 2013. That upward trajectory is not accidental — it reflects sustained, multi-ministerial government investment and a 10-year national wellness strategy running from 2025 to 2034.

Clinical strengths

Cardiac surgery scores at the top of our rubric. Bumrungrad International Hospital's in-hospital CABG mortality rate of 1.62% meets the most demanding international benchmarks, and the country's top centres offer 24/7 emergency capability backed by imaging and perfusion teams that would be recognisable in any major Western cardiac unit. Bariatric surgery sits at 4.5 out of 5: more than 40 JCI-accredited facilities offer the full procedural range including robotic-assisted surgery, with outcomes data that comfortably meets Score 5 criteria on most dimensions.

Dental care is a consistent five. Cost savings of 60–70% against Western comparators are transparent and comprehensive, with all-inclusive packages that eliminate the billing surprises common in other destinations. Cosmetic and aesthetic surgery runs at 4.5 — cost savings of 50–70% (often 70–80% on specific procedures) are matched by specialist credentials that include Western fellowship training and board certification, though formal outcome registries are less developed than in the top-tier European comparators.

Oncology is stronger than the headline figure suggests. Two ESMO Designated Centres of Integrated Oncology and Palliative Care operate in Bangkok (Wattanosoth and Chulabhorn hospitals), radiation therapy scores 4.5, and second-opinion services — including formal oncology programmes with sub-48-hour turnaround — score a full 5. Cancer treatment cost savings reach 50–70% against US or Australian pricing.

Stem cell and regenerative medicine represent a notable frontier strength. Thailand scores 5 for stem cell therapy availability, with 10+ dedicated clinics and extensive hospital networks offering the full spectrum of cell types (UC-MSCs, adipose-derived, bone marrow). The exosome market is expanding rapidly. The regulatory framework is present but evolving, which makes due diligence on individual provider credentials especially important in this segment.

Wellness and recovery

Thailand's wellness infrastructure is in a category of its own. The government's coordinated clustering strategy — spanning Bangkok, Chiang Mai, Phuket, Hua Hin, and Koh Samui — means that post-surgical recovery and wellness tourism are not afterthoughts but fully developed parallel industries. Dedicated recovery facilities with 24/7 nursing supervision, wound-care services, and physiotherapy are widely available across all major medical hubs, scoring a maximum 5. The same applies to traditional medicine (Thai massage, herbal medicine) and executive health screening packages, which are world-class both in technology and in concierge delivery.

What Thailand cannot offer

The legal environment draws firm lines on several categories. Surrogacy is illegal for foreigners following the 2015 Assisted Reproductive Technology Act, scoring a 1 on both legality and cost — a hard stop. Egg and sperm donation for foreigners is effectively closed, also scoring 1. Assisted dying is not legal in any form and scores 1 across all related factors. Psychedelic-assisted therapy (ayahuasca, ibogaine, ketamine clinics) remains largely unavailable or operating in legal grey zones that do not constitute a reliable pathway for international patients. Ayurveda and classical Indian-style naturopathy score 2 — Thailand's traditional medicine system is Thai-specific and does not replicate the South Asian modalities for which India is the reference destination.

Abortion access is a qualified 4: legal on request to 12 weeks, with accessible pricing and dedicated providers for international patients, but gestational limits and the small number of internationally oriented clinics mean it is not unrestricted.

Practicalities

Thailand issues a 90-day medical visa (Non-Immigrant Type O-A health) supported by a straightforward application process through Thai embassies, and the major Bangkok hospitals have international patient divisions that manage the entire administrative journey — translation, insurance liaison, pre-arrival records coordination, airport transfers. Specialist credentials are solid: a rigorous 6-year medical degree followed by 3–6 years of specialty residency, with a high proportion of senior surgeons holding fellowships from the US, UK, or Australia. The Thai Medical Council's disciplinary oversight adds a further layer of professional accountability that not all regional competitors can match.

The honest summary for a prospective patient: Thailand is the default choice for high-volume elective procedures — cardiac, orthopedic, cosmetic, dental, bariatric, oncology, and wellness — where cost savings of 50–89% do not require sacrificing JCI-level institutional standards. Where it falls short is in reproduction-adjacent services and anything requiring a permissive legal posture that Thailand's regulatory environment does not provide.